Cargando…
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
AIMS: Sacubitril/Valsartan (Sac/Val) was proven more effective than enalapril for symptomatic patients with heart failure (HF) with reduced ejection fraction (HFrEF). This study aimed to investigate eligibility, titration, and tolerability for Sac/Val in a real‐world clinical setting. METHODS AND RE...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261574/ https://www.ncbi.nlm.nih.gov/pubmed/32030899 http://dx.doi.org/10.1002/ehf2.12644 |